Published in Medical Letter on the CDC and FDA, June 13th, 2004
Sage is the first in a planned family of oxygen therapeutic devices that use Chad's proprietary technologies to sense a patient's movements and automatically adjust the rate of oxygen delivery to reduce the risk of desaturation as activity increases.
Shipments are expected to begin this month.
"Combining the industry's first truly dynamic delivery technology with the proven oxygen sensor technology in our Oxymatic 400 series conserver, Chad's new Sage Oxygen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA